New step in the treatment of prostate cancer

Newscastle virus in chickens can become an effective remedy for treating prostate cancer in humans.

>>>Estrogen patches treat prostate cancer

This is the conclusion of a study conducted by the American team and published in the Journal of Virology published on April 8.

The Xinhua News Agency reported on the report that the newscastle virus (Newscastle virus) causes conjunctivitis in wild birds and birds but does not harm human health, except for some flu symptoms. mild appearance in people who have direct contact with infected animals.

Newscatstle virus

However, thanks to the application of new gene transfer technology, the team has successfully transformed the Newscastle virus into a new virus capable of killing all prostate cancer cells.

The head of the research group, Elankumaran Subbiah, said that after being genetically engineered, Newscastle viruses "new versions" can only be cloned when exposed to prostate-specific antigens (PSA) and, therefore, particularly liked. suitable for the treatment of prostate cancer.

According to team leader Subbiah, his team has successfully tested this method in the laboratory, in which during the cloning process, recombinant Newscastle viruses only focus on removing and effectively eliminating the Prostate cancer cells without harming other normal cells. In addition, these viruses also kill cancer cells that have spread.

Although there are many procedures and it takes a long time to bring this new invention into a cancer treatment in practice, Mr. Subbiah still believes that the new virus will help to effectively prevent money cancer. Paralysis with a much lower dose of medication than current treatments.

Not only that, the new treatment also reduces side effects compared to hormone therapy and chemotherapy, and can be administered directly into the vein or directly to the tumor thanks to high safety. .

The research team said that it is applying for a license and seeking partners to cooperate in the application of new therapies in human clinical trials.